Becotatug vedotin

DB17407Investigational

MRG-003 is a recombinant humanized anti-human epidermal growth factor receptor monoclonal antibody conjugated to monomethyl auristatin E.

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Also known as: Becotatugvedotin
Code names: MRG-003

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

52Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Becotatug vedotin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.